Role of virulence factors on host inflammatory response induced by diarrheagenic Escherichia coli pathotypes

Future Microbiology

Volumn 10, Issue 6, 2015, Pages 1009-1033

  Sanchez Villamil, Javier ^a   Navarro Garcia, Fernando ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

bacterial effector; diarrheagenic E. Coli; epithelial cells; intestinal inflammation; pathogenesis; proinflammatory cytokines; signaling pathway; toxins

Indexed keywords

BACTERIAL PROTEIN; CYCLIC GMP DEPENDENT PROTEIN KINASE 2; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FLAGELLIN; GAMMA INTERFERON; GANGLIOSIDE GD 1A; GANGLIOSIDE GD 1B; GANGLIOSIDE GM1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MYELOID DIFFERENTIATION FACTOR 88; PROSTAGLANDIN E2; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 5; TUMOR NECROSIS FACTOR ALPHA; VIRULENCE FACTOR;

ANTIINFLAMMATORY ACTIVITY; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL SURVIVAL; CELL FUNCTION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DIARRHEAGENIC ESCHERICHIA COLI; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ENTEROPATHOGENIC ESCHERICHIA COLI; ENZYME PHOSPHORYLATION; ESCHERICHIA COLI; GENE EXPRESSION; GENETIC PREDISPOSITION; HOST CELL; HOST RESISTANCE; HUMAN; INFLAMMATION; INNATE IMMUNITY; LYMPHOCYTE PROLIFERATION; NONHUMAN; PATHOGENICITY; PATHOTYPE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; DISEASE MODEL; ENTEROTOXIGENIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; HOST PATHOGEN INTERACTION; METABOLISM; MICROBIOLOGY; PATHOLOGY;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

ANIMALS; DISEASE MODELS, ANIMAL; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ENTEROPATHOGENIC ESCHERICHIA COLI; ENTEROTOXIGENIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLAMMATION; VIRULENCE FACTORS;

EID: 84930986928     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.15.17     Document Type: Review

References (176)

1. Hooper LV, Bry L, Falk PG, Gordon JI. Host-microbial symbiosis in the mammalian intestine: exploring an internal ecosystem. BioEssays 20(4), 336-343 (1998).
2. Yu Y, Zeng H, Vijay-Kumar M et al. STAT signaling underlies difference between flagellin-induced and tumor necrosis factor-alpha-induced epithelial gene expression. J. Biol. Chem. 279(34), 35210-35218 (2004).
3. Lupp C, Robertson ML, Wickham ME et al. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2(3), 204 (2007).
4. Kuehl CJ, Wood HD, Marsh TL, Schmidt TM, Young VB. Colonization of the cecal mucosa by Helicobacter hepaticus impacts the diversity of the indigenous microbiota. Infect. Immun. 73(10), 6952-6961 (2005).
5. Reid G, Howard J, Gan BS. Can bacterial interference prevent infection? Trends Microbiol. 9(9), 424-428 (2001).
6. Sansonetti PJ. War and peace at mucosal surfaces. Nat. Rev. Immunol. 4(12), 953-964 (2004).
7. Bhavsar AP, Guttman JA, Finlay BB. Manipulation of host-cell pathways by bacterial pathogens. Nature 449(7164), 827-834 (2007).
8. Dommett R, Zilbauer M, George JT, Bajaj-Elliott M. Innate immune defence in the human gastrointestinal tract. Mol. Immunol. 42(8), 903-912 (2005).
9. Svanborg C, Godaly G, Hedlund M. Cytokine responses during mucosal infections: role in disease pathogenesis and host defence. Curr. Opin. Microbiol. 2(1), 99-105 (1999).
10. Kumar S, Ingle H, Prasad DV, Kumar H. Recognition of bacterial infection by innate immune sensors. Crit. Rev. Microbiol. 39(3), 229-246 (2013).
11. Kumar H, Kawai T, Akira S. Pathogen recognition in the innate immune response. Biochem. J. 420(1), 1-16 (2009).
12. Mogensen TH. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin. Microbiol. Rev.22(2), 240-273 (2009).
13. Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature 406(6797), 782-787 (2000).
14. Bonizzi G, Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25(6), 280-288 (2004).
15. Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16, 225-260 (1998).
16. Zhang YL, Dong C. MAP kinases in immune responses. Cell. Mol. Immunol. 2(1), 20-27 (2005).
17. Kawai T, Adachi O, Ogawa T, Takeda K, Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11(1), 115-122 (1999).
18. Muzio M, Ni J, Feng P, Dixit VM. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science 278(5343), 1612-1615 (1997).
19. Savkovic SD, Koutsouris A, Hecht G. Activation of NF-kappaB in intestinal epithelial cells by enteropathogenic Escherichia coli. Am. J. Physiol. 273(4 Pt 1), C1160-1167 (1997).
20. Hoffmann E, Dittrich-Breiholz O, Holtmann H, Kracht M. Multiple control of interleukin-8 gene expression. J. Leuk. Biol. 72(5), 847-855 (2002).
21. Savkovic SD, Ramaswamy A, Koutsouris A, Hecht G. EPEC-activated ERK1/2 participate in inflammatory response but not tight junction barrier disruption. Am. J. Physiol. Gastrointest. Liver Physiol. 281(4), G890-G898 (2001).
22. Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol. Cell 10(2), 417-426 (2002).
23. Martinon F, Tschopp J. Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ. 14(1), 10-22 (2007).
24. Martinon F, Mayor A, Tschopp J. The inflammasomes: guardians of the body. Annu. Rev. Immunol. 27, 229-265 (2009).
25. Fink SL, Cookson BT. Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect. Immun. 73(4), 1907-1916 (2005).
26. Kaper JB, Nataro JP, Mobley HL. Pathogenic Escherichia coli. Nat. Rev. Microbiol. 2(2), 123-140 (2004).
27. Navarro-Garcia F, Serapio-Palacios A, Ugalde-Silva P, Tapia-Pastrana G, Chavez-Duenas L. Actin cytoskeleton manipulation by effector proteins secreted by diarrheagenic Escherichia coli pathotypes. Biomed. Res. Int. 2013, 374395 (2013).
28. Wong AR, Pearson JS, Bright MD et al. Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements. Mol. Microbiol. 80(6), 1420-1438 (2011).
29. Deane JE, Abrusci P, Johnson S, Lea SM. Timing is everything: the regulation of type III secretion. Cell. Mol. Life Sci. 67(7), 1065-1075 (2010).
30. Mills E, Baruch K, Charpentier X, Kobi S, Rosenshine I. Real-time analysis of effector translocation by the type III secretion system of enteropathogenic Escherichia coli. Cell Host Microbe 3(2), 104-113 (2008).
31. Robins-Browne RM, Hartland EL. Escherichia coli as a cause of diarrhea. J. Gastroenterol. Hepatol. 17(4), 467-475 (2002).
32. Zhou X, Giron JA, Torres AG et al. Flagellin of enteropathogenic Escherichia coli stimulates interleukin-8 production in T84 cells. Infect. Immun. 71(4), 2120-2129 (2003).
33. Malladi V, Puthenedam M, Williams PH, Balakrishnan A. Enteropathogenic Escherichia coli outer membrane proteins induce iNOS by activation of NF-kappaB and MAP kinases. Inflammation 28(6), 345-353 (2004).
34. Hayashi F, Smith KD, Ozinsky A et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410(6832), 1099-1103 (2001).
35. Savkovic SD, Koutsouris A, Hecht G. PKC zeta participates in activation of inflammatory response induced by enteropathogenic E. Coli. Am. J. Physiol. Cell Physiol. 285(3), C512-C521 (2003).
36. Czerucka D, Dahan S, Mograbi B, Rossi B, Rampal P. Implication of mitogen-activated protein kinases in T84 cell responses to enteropathogenic Escherichia coli infection. Infect. Immun. 69(3), 1298-1305 (2001).
37. Khan MA, Bouzari S, Ma C et al. Flagellindependent and-independent inflammatory responses following infection by enteropathogenic Escherichia coli and Citrobacter rodentium. Infect. Immun. 76(4), 1410-1422 (2008).
38. Zurawski DV, Mumy KL, Badea L et al. The NleE/OspZ family of effector proteins is required for polymorphonuclear transepithelial migration, a characteristic shared by enteropathogenic Escherichia coli and Shigella flexneri infections. Infect. Immun. 76(1), 369-379 (2008).
39. Nadler C, Baruch K, Kobi S et al. The type III secretion effector NleE inhibits NFkappaB activation. PLoS Pathog. 6(1), e1000743 (2010).
40. Newton HJ, Pearson JS, Badea L et al. The type III effectors NleE and NleB from enteropathogenic E. Coli and OspZ from Shigella block nuclear translocation of NF-kappaB p65. PLoS Pathog. 6(5), e1000898 (2010).
41. Vossenkamper A, Marches O, Fairclough PD et al. Inhibition of NF-kappaB signaling in human dendritic cells by the enteropathogenic Escherichia coli effector protein NleE. J. Immunol. 185(7), 4118-4127 (2010).
42. Gao X, Wang X, Pham TH et al. NleB, a bacterial effector with glycosyltransferase activity, targets GAPDH function to inhibit NF-kappaB activation. Cell Host Microbe 13(1), 87-99 (2013).
43. Li S, Zhang L, Yao Q et al. Pathogen blocks host death receptor signalling by arginine GlcNAcylation of death domains. Nature 501(7466), 242-246 (2013).
44. Baruch K, Gur-Arie L, Nadler C et al. Metalloprotease type III effectors that specifically cleave JNK and NF-kappaB. EMBO J. 30(1), 221-231 (2011).
45. Yen H, Ooka T, Iguchi A, Hayashi T, Sugimoto N, Tobe T. NleC, a type III secretion protease, compromises NF-kappaB activation by targeting p65/RelA. PLoS Pathog. 6(12), e1001231 (2010).
46. Pearson JS, Riedmaier P, Marches O, Frankel G, Hartland EL. A type III effector protease NleC from enteropathogenic Escherichia coli targets NF-kappaB for degradation. Mol. Microbiol. 80(1), 219-230 (2011).
47. Sham HP, Shames SR, Croxen MA et al. Attaching and effacing bacterial effector NleC suppresses epithelial inflammatory responses by inhibiting NF-kappaB and p38 mitogen-activated protein kinase activation. Infect. Immun. 79(9), 3552-3562 (2011).
48. Muhlen S, Ruchaud-Sparagano MH, Kenny B. Proteasome-independent degradation of canonical NFkappaB complex components by the NleC protein of pathogenic Escherichia coli. J. Biol. Chem. 286(7), 5100-5107 (2011).
49. Kim DW, Lenzen G, Page AL, Legrain P, Sansonetti PJ, Parsot C. The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes. Proc. Natl Acad. Sci. USA 102(39), 14046-14051 (2005).
50. Royan SV, Jones RM, Koutsouris A et al. Enteropathogenic E. Coli non-LEE encoded effectors NleH1 and NleH2 attenuate NF-kappaB activation. Mol. Microbiol. 78(5), 1232-1245 (2010).
51. Ruchaud-Sparagano MH, Muhlen S, Dean P, Kenny B. The enteropathogenic E. Coli (EPEC) Tir effector inhibits NF-kappaB activity by targeting TNFalpha receptorassociated factors. PLoS Pathog. 7(12), e1002414 (2011).
52. Zhang J, Somani AK, Siminovitch KA. Roles of the SHP-1 tyrosine phosphatase in the negative regulation of cell signalling. Semin. Immunol. 12(4), 361-378 (2000).
53. Yan D, Wang X, Luo L, Cao X, Ge B. Inhibition of TLR signaling by a bacterial protein containing immunoreceptor tyrosine-based inhibitory motifs. Nat. Immunol. 13(11), 1063-1071 (2012).
54. Cui J, Yao Q, Li S et al. Glutamine deamidation and dysfunction of ubiquitin/NEDD8 induced by a bacterial effector family. Science 329(5996), 1215-1218 (2010).
55. Klapproth JM, Scaletsky IC, Mcnamara BP et al. A large toxin from pathogenic Escherichia coli strains that inhibits lymphocyte activation. Infect. Immun. 68(4), 2148-2155 (2000).
56. Edwards LA, Bajaj-Elliott M, Klein NJ, Murch SH, Phillips AD. Bacterial-epithelial contact is a key determinant of host innate immune responses to enteropathogenic and enteroaggregative Escherichia coli. PLoS ONE 6(10), e27030 (2011).
57. Alto NM, Shao F, Lazar CS et al. Identification of a bacterial type III effector family with G protein mimicry functions. Cell 124(1), 133-145 (2006).
58. Raymond B, Crepin VF, Collins JW, Frankel G. The WxxxE effector EspT triggers expression of immune mediators in an Erk/JNK and NF-kappaB-dependent manner. Cell. Microbiol. 13(12), 1881-1893 (2011).
59. Ramirez K, Huerta R, Oswald E, Garcia-Tovar C, Hernandez JM, Navarro-Garcia F. Role of EspA and intimin in expression of proinflammatory cytokines from enterocytes and lymphocytes by rabbit enteropathogenic Escherichia coli-infected rabbits. Infect. Immun. 73(1), 103-113 (2005).
60. Salazar-Gonzalez H, Navarro-Garcia F. Intimate adherence by enteropathogenic Escherichia coli modulates TLR5 localization and proinflammatory host response in intestinal epithelial cells. Scand. J. Immunol. 73(4), 268-283 (2011).
61. Foubister V, Rosenshine I, Donnenberg MS, Finlay BB. The eaeB gene of enteropathogenic Escherichia coli is necessary for signal transduction in epithelial cells. Infect. Immun. 62(7), 3038-3040 (1994).
62. Savkovic SD, Koutsouris A, Hecht G. Attachment of a noninvasive enteric pathogen, enteropathogenic Escherichia coli, to cultured human intestinal epithelial monolayers induces transmigration of neutrophils. Infect. Immun. 64(11), 4480-4487 (1996).
63. Choi HJ, Kim J, Do KH, Park SH, Moon Y. Prolonged NF-kappaB activation by a macrophage inhibitory cytokine 1-linked signal in enteropathogenic Escherichia coli-infected epithelial cells. Infect. Immun. 81(6), 1860-1869 (2013).
64. Hernandes RT, Elias WP, Vieira MA, Gomes TA. An overview of atypical enteropathogenic Escherichia coli. FEMS Microbiol. Lett. 297(2), 137-149 (2009).
65. Sampaio SC, Gomes TA, Pichon C et al. The flagella of an atypical enteropathogenic Escherichia coli strain are required for efficient interaction with and stimulation of interleukin-8 production by enterocytes in vitro. Infect. Immun. 77(10), 4406-4413 (2009).
66. Besser RE, Griffin PM, Slutsker L. Escherichia coli O157:H7 gastroenteritis and the hemolytic uremic syndrome: an emerging infectious disease. Ann. Rev. Med. 50, 355-367 (1999).
67. Berin MC, Darfeuille-Michaud A, Egan LJ, Miyamoto Y, Kagnoff MF. Role of EHEC O157:H7 virulence factors in the activation of intestinal epithelial cell NF-kappaB and MAP kinase pathways and the upregulated expression of interleukin 8. Cell. Microbiol. 4(10), 635-648 (2002).
68. Farfan MJ, Cantero L, Vergara A, Vidal R, Torres AG. The long polar fimbriae of STEC O157:H7 induce expression of proinflammatory markers by intestinal epithelial cells. Vet. Immunol. Immunopathol. 152(1-2), 126-131 (2013).
69. Dahan S, Busuttil V, Imbert V, Peyron JF, Rampal P, Czerucka D. Enterohemorrhagic Escherichia coli infection induces interleukin-8 production via activation of mitogen-activated protein kinases and the transcription factors NF-kappaB and AP-1 in T84 cells. Infect. Immun. 70(5), 2304-2310 (2002).
70. Jeannin P, Magistrelli G, Goetsch L et al. Outer membrane protein A (OmpA): a new pathogen-associated molecular pattern that interacts with antigen presenting cells-impact on vaccine strategies. Vaccine 20(Suppl. 4), A23-A27 (2002).
71. Torres AG, Li Y, Tutt CB, Xin L, Eaves-Pyles T, Soong L. Outer membrane protein A of Escherichia coli O157:H7 stimulates dendritic cell activation. Infect. Immun. 74(5), 2676-2685 (2006).
72. Sakiri R, Ramegowda B, Tesh VL. Shiga toxin type 1 activates tumor necrosis factor-alpha gene transcription and nuclear translocation of the transcriptional activators nuclear factor-kappaB and activator protein-1. Blood 92(2), 558-566 (1998).
73. Cheng YL, Song LQ, Huang YM et al. Effect of enterohemorrhagic Escherichia coli O157:H7-Specific enterohemolysin on interleukin-1beta production differs between human and mouse macrophages due to the different sensitivity of NLRP3 activation. Immunology doi:10.1111/imm.12442 (2015) (Epub ahead of print).
74. Jandhyala DM, Rogers TJ, Kane A, Paton AW, Paton JC, Thorpe CM. Shiga toxin 2 and flagellin from shiga-toxigenic Escherichia coli superinduce interleukin-8 through synergistic effects on host stress-activated protein kinase activation. Infect. Immun. 78(7), 2984-2994 (2010).
75. Chou TC, Chiu HC, Kuo CJ et al. Enterohaemorrhagic Escherichia coli O157:H7 Shiga-like toxin 1 is required for full pathogenicity and activation of the p38 mitogen-activated protein kinase pathway in Caenorhabditis elegans. Cell. Microbiol. 15(1), 82-97 (2013).
76. Bellmeyer A, Cotton C, Kanteti R, Koutsouris A, Viswanathan VK, Hecht G. Enterohemorrhagic Escherichia coli suppresses inflammatory response to cytokines and its own toxin. Am. J. Physiol. Gastrointest. Liver Physiol. 297(3), G576-G581 (2009).
77. Hauf N, Chakraborty T. Suppression of NF-kappa B activation and proinflammatory cytokine expression by Shiga toxin-producing Escherichia coli. J. Immunol. 170(4), 2074-2082 (2003).
78. Gobert AP, Vareille M, Glasser AL, Hindre T, De Sablet T, Martin C. Shiga toxin produced by enterohemorrhagic Escherichia coli inhibits PI3K/NF-kappaB signaling pathway in globotriaosylceramide-3-negative human intestinal epithelial cells. J. Immunol. 178(12), 8168-8174 (2007).
79. Tsutsuki H, Yahiro K, Suzuki K et al. Subtilase cytotoxin enhances Escherichia coli survival in macrophages by suppression of nitric oxide production through the inhibition of NF-kappaB activation. Infect. Immun. 80(11), 3939-3951 (2012).
80. Gao X, Wan F, Mateo K et al. Bacterial effector binding to ribosomal protein s3 subverts NF-kappaB function. PLoS Pathog. 5(12), e1000708 (2009).
81. Pham TH, Gao X, Tsai K, Olsen R, Wan F, Hardwidge PR. Functional differences and interactions between the Escherichia coli type III secretion system effectors NleH1 and NleH2. Infect. Immun. 80(6), 2133-2140 (2012).
82. Wan F, Weaver A, Gao X, Bern M, Hardwidge PR, Lenardo MJ. IKKbeta phosphorylation regulates RPS3 nuclear translocation and NF-kappaB function during infection with Escherichia coli strain O157:H7. Nat. Immunol. 12(4), 335-343 (2011).
83. Zhou Y, Dong N, Hu L, Shao F. The Shigella type three secretion system effector OspG directly and specifically binds to host ubiquitin for activation. PLoS ONE 8(2), e57558 (2013).
84. Nobe R, Nougayrede JP, Taieb F et al. Enterohaemorrhagic Escherichia coli serogroup O111 inhibits NF-(kappa)B-dependent innate responses in a manner independent of a type III secreted OspG orthologue. Microbiology 155(Pt 10), 3214-3225 (2009).
85. Lathem WW, Grys TE, Witowski SE et al. StcE, a metalloprotease secreted by Escherichia coli O157:H7, specifically cleaves C1 esterase inhibitor. Mol. Microbiol. 45(2), 277-288 (2002).
86. Szabady RL, Lokuta MA, Walters KB, Huttenlocher A, Welch RA. Modulation of neutrophil function by a secreted mucinase of Escherichia coli O157:H7. PLoS Pathog. 5(2), e1000320 (2009).
87. Gobert AP, Wilson KT, Martin C. Cellular responses to attaching and effacing bacteria: activation and implication of the innate immune system. Arch. Immunol. Ther. Exp. (Warsz). 53(3), 234-244 (2005).
88. Qadri F, Svennerholm AM, Faruque AS, Sack RB. Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention. Clin. Microbiol. Rev.18(3), 465-483 (2005).
89. Wolf MK. Occurrence, distribution, and associations of O and H serogroups, colonization factor antigens, and toxins of enterotoxigenic Escherichia coli. Clin. Microbiol. Rev. 10(4), 569-584 (1997).
90. Sixma TK, Pronk SE, Kalk KH et al. Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. Coli. Nature 351(6325), 371-377 (1991).
91. Sears CL, Kaper JB. Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion. Microbiol. Rev. 60(1), 167-215 (1996).
92. Liang S, Hajishengallis G. Heat-labile enterotoxins as adjuvants or antiinflammatory agents. Immunol. Invest. 39(4-5), 449-467 (2010).
93. Blanco J, Blanco M, Garabal JI, Gonzalez EA. Enterotoxins, colonization factors and serotypes of enterotoxigenic Escherichia coli from humans and animals. Microbiologia 7(2), 57-73 (1991).
94. Hughes JM, Murad F, Chang B, Guerrant RL. Role of cyclic GMP in the action of heat-stable enterotoxin of Escherichia coli. Nature 271(5647), 755-756 (1978).
95. Chao AC, De Sauvage FJ, Dong YJ, Wagner JA, Goeddel DV, Gardner P. Activation of intestinal CFTR Cl-channel by heat-stable enterotoxin and guanylin via cAMPdependent protein kinase. EMBO J. 13(5), 1065-1072 (1994).
96. Huang DB, Dupont HL. Enteroaggregative Escherichia coli: an emerging pathogen in children. Semin. Pediatr. Infect. Dis. 15(4), 266-271 (2004).
97. Nataro JP, Deng Y, Cookson S et al. Heterogeneity of enteroaggregative Escherichia coli virulence demonstrated in volunteers. J. Infect. Dis. 171(2), 465-468 (1995).
98. Vial PA, Robins-Browne R, Lior H et al. Characterization of enteroadherentaggregative Escherichia coli, a putative agent of diarrheal disease. J. Infect. Dis. 158(1), 70-79 (1988).
99. Harrington SM, Dudley EG, Nataro JP. Pathogenesis of enteroaggregative Escherichia coli infection. FEMS Microbiol. Lett. 254(1), 12-18 (2006).
100. Boisen N, Struve C, Scheutz F, Krogfelt KA, Nataro JP. New adhesin of enteroaggregative Escherichia coli related to the Afa/Dr/AAF family. Infect. Immun. 76(7), 3281-3292 (2008).
101. Estrada-Garcia T, Navarro-Garcia F. Enteroaggregative Escherichia coli pathotype: a genetically heterogeneous emerging foodborne enteropathogen. FEMS Immunol. Med. Microbiol. 66(3), 281-298 (2012).
102. Wang X, Gao X, Hardwidge PR. Heat-labile enterotoxin-induced activation of NF-kappaB and MAPK pathways in intestinal epithelial cells impacts enterotoxigenic Escherichia coli (ETEC) adherence. Cell. Microbiol. 14(8), 1231-1241 (2012).
103. Horstman AL, Kuehn MJ. Enterotoxigenic Escherichia coli secretes active heat-labile enterotoxin via outer membrane vesicles. J. Biol. Chem. 275(17), 12489-12496 (2000).
104. Chutkan H, Kuehn MJ. Context-dependent activation kinetics elicited by soluble versus outer membrane vesicle-associated heat-labile enterotoxin. Infect. Immun. 79(9), 3760-3769 (2011).
105. Park KS, Choi KH, Kim YS et al. Outer membrane vesicles derived from Escherichia coli induce systemic inflammatory response syndrome. PLoS ONE 5(6), e11334 (2010).
106. Huang DB, Dupont HL, Jiang ZD, Carlin L, Okhuysen PC. Interleukin-8 response in an intestinal HCT-8 cell line infected with enteroaggregative and enterotoxigenic Escherichia coli. Clin. Diagn. Lab. Immunol. 11(3), 548-551 (2004).
107. Liang S, Wang M, Tapping RI et al. Ganglioside GD1a is an essential coreceptor for Toll-like receptor 2 signaling in response to the B subunit of type IIb enterotoxin. J. Biol. Chem. 282(10), 7532-7542 (2007).
108. Liang S, Wang M, Triantafilou K et al. The A subunit of type IIb enterotoxin (LT-IIb) suppresses the proinflammatory potential of the B subunit and its ability to recruit and interact with TLR2. J. Immunol. 178(8), 4811-4819 (2007).
109. Krais AM, Muhlbauer KR, Kucab JE et al. Comparison of the metabolic activation of environmental carcinogens in mouse embryonic stem cells and mouse embryonic fibroblasts. Toxicol. In Vitro 29(1), 34-43 (2014).
110. Hajishengallis G, Nawar H, Tapping RI, Russell MW, Connell TD. The type II heat-labile enterotoxins LT-IIa and LT-IIb and their respective B pentamers differentially induce and regulate cytokine production in human monocytic cells. Infect. Immun. 72(11), 6351-6358 (2004).
111. Wang X, Hardwidge PR. Enterotoxigenic Escherichia coli prevents host NF-kappaB activation by targeting IkappaBalpha polyubiquitination. Infect. Immun. 80(12), 4417-4425 (2012).
112. Steiner TS, Lima AA, Nataro JP, Guerrant RL. Enteroaggregative Escherichia coli produce intestinal inflammation and growth impairment and cause interleukin-8 release from intestinal epithelial cells. J. Infect. Dis. 177(1), 88-96 (1998).
113. Steiner TS, Nataro JP, Poteet-Smith CE, Smith JA, Guerrant RL. Enteroaggregative Escherichia coli expresses a novel flagellin that causes IL-8 release from intestinal epithelial cells. J. Clin. Invest. 105(12), 1769-1777 (2000).
114. Harrington SM, Strauman MC, Abe CM, Nataro JP. Aggregative adherence fimbriae contribute to the inflammatory response of epithelial cells infected with enteroaggregative Escherichia coli. Cell. Microbiol. 7(11), 1565-1578 (2005).
115. Khan MA, Kang J, Steiner TS. Enteroaggregative Escherichia coli flagellininduced interleukin-8 secretion requires Toll-like receptor 5-dependent p38 MAP kinase activation. Immunology 112(4), 651-660 (2004).
116. Carvalho FA, Barnich N, Sauvanet P, Darcha C, Gelot A, Darfeuille-Michaud A. Crohn's disease-associated Escherichia coli LF82 aggravates colitis in injured mouse colon via signaling by flagellin. Inflamm. Bowel Dis. 14(8), 1051-1060 (2008).
117. Goyal A, Bhattacharyya S, Majumdar S, Narang A, Ghosh S. Cellular response induced by a galactose-specific adhesin of enteroaggregative Escherichia coli in INT-407 cells. FEMS Immunol. Med. Microbiol. 55(3), 378-387 (2009).
118. Goyal A, Konar M, Setia A, Narang A, Ghosh S. Galactose specific adhesin of enteroaggregative E. Coli induces IL-8 secretion via activation of MAPK and STAT-3 in INT-407 cells. Biochim. Biophys. Acta 1800(6), 574-579 (2010).
119. Khan K, Konar M, Goyal A, Ghosh S. Enteroaggregative Escherichia coli infection induces IL-8 production via activation of mitogen-activated protein kinases and the transcription factors NF-kappaB and AP-1 in INT-407 cells. Mol. Cell. Biochem. 337(1-2), 17-24 (2010).
120. Boll EJ, Struve C, Sander A, Demma Z, Krogfelt KA, Mccormick BA. Enteroaggregative Escherichia coli promotes transepithelial migration of neutrophils through a conserved 12-lipoxygenase pathway. Cell. Microbiol. 14(1), 120-132 (2012).
121. Jiang ZD, Okhuysen PC, Guo DC et al. Genetic susceptibility to enteroaggregative Escherichia coli diarrhea: polymorphism in the interleukin-8 promotor region. J. Infect. Dis. 188(4), 506-511 (2003).
122. Mohamed JA, Dupont HL, Jiang ZD et al. A novel single-nucleotide polymorphism in the lactoferrin gene is associated with susceptibility to diarrhea in North American travelers to Mexico. Clin. Infect. Dis. 44(7), 945-952 (2007).
123. Boll EJ, Struve C, Sander A et al. The fimbriae of enteroaggregative Escherichia coli induce epithelial inflammation in vitro and in a human intestinal xenograft model. J. Infect. Dis. 206(5), 714-722 (2012).
124. Ruiz-Perez F, Wahid R, Faherty CS et al. Serine protease autotransporters from Shigella flexneri and pathogenic Escherichia coli target a broad range of leukocyte glycoproteins. Proc. Natl Acad. Sci. USA 108(31), 12881-12886 (2011).
125. Dupont HL, Levine MM, Hornick RB, Formal SB. Inoculum size in shigellosis and implications for expected mode of transmission. J. Infect. Dis. 159(6), 1126-1128 (1989).
126. Bando SY, Moreno AC, Albuquerque JA, Amhaz JM, Moreira-Filho CA, Martinez MB. Expression of bacterial virulence factors and cytokines during in vitro macrophage infection by enteroinvasive Escherichia coli and Shigella flexneri: a comparative study. Memorias do Instituto Oswaldo Cruz 105(6), 786-791 (2010).
127. Nataro JP, Kaper JB. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev.11(1), 142-201 (1998).
128. Maurelli AT, Sansonetti PJ. Genetic determinants of Shigella pathogenicity. Annu. Rev. Microbiol. 42, 127-150 (1988).
129. Sansonetti PJ, Egile C. Molecular bases of epithelial cell invasion by Shigella flexneri. Antonie van Leeuwenhoek 74(4), 191-197 (1998).
130. Vasselon T, Mounier J, Hellio R, Sansonetti PJ. Movement along actin filaments of the perijunctional area and de novo polymerization of cellular actin are required for Shigella flexneri colonization of epithelial Caco-2 cell monolayers. Infect. Immun. 60(3), 1031-1040 (1992).
131. Goldberg MB, Barzu O, Parsot C, Sansonetti PJ. Unipolar localization and ATPase activity of IcsA, a Shigella flexneri protein involved in intracellular movement. J. Bacteriol. 175(8), 2189-2196 (1993).
132. Carayol N, Tran Van Nhieu G. Tips and tricks about Shigella invasion of epithelial cells. Curr. Opin. Microbiol. 16(1), 32-37 (2013).
133. Tran Van Nhieu G, Ben-Ze'ev A, Sansonetti PJ. Modulation of bacterial oasis:entry into epithelial cells by association between vinculin and the Shigella IpaA invasin. EMBO J. 16(10), 2717-2729 (1997).
134. Girardin SE, Tournebize R, Mavris M et al. CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri. EMBO Rep. 2(8), 736-742 (2001).
135. Philpott DJ, Yamaoka S, Israel A, Sansonetti PJ. Invasive Shigella flexneri activates NF-kappa B through a lipopolysaccharidedependent innate intracellular response and leads to IL-8 expression in epithelial cells. J. Immunol. 165(2), 903-914 (2000).
136. Kanneganti TD, Lamkanfi M, Nunez G. Intracellular NOD-like receptors in host defense and disease. Immunity 27(4), 549-559 (2007).
137. Fukazawa A, Alonso C, Kurachi K et al. GEF-H1 mediated control of NOD1 dependent NF-kappaB activation by Shigella effectors. PLoS Pathog. 4(11), e1000228 (2008).
138. Suzuki S, Franchi L, He Y et al. Shigella type III secretion protein MxiI is recognized by Naip2 to induce Nlrc4 inflammasome activation independently of Pkcdelta. PLoS Pathog. 10(2), e1003926 (2014).
139. Suzuki S, Mimuro H, Kim M et al. Shigella IpaH7.8 E3 ubiquitin ligase targets glomulin and activates inflammasomes to demolish macrophages. Proc. Natl Acad. Sci. USA 111(40), E4254-E4263 (2014).
140. Wang F, Jiang Z, Li Y et al. Shigella flexneri T3SS effector IpaH4.5 modulates the host inflammatory response via interaction with NF-kappaB p65 protein. Cell. Microbiol. 15(3), 474-485 (2013).
141. Elewaut D, Didonato JA, Kim JM, Truong F, Eckmann L, Kagnoff MF. NF-kappa B is a central regulator of the intestinal epithelial cell innate immune response induced by infection with enteroinvasive bacteria. J. Immunol. 163(3), 1457-1466 (1999).
142. Ashida H, Kim M, Schmidt-Supprian M, Ma A, Ogawa M, Sasakawa C. A bacterial E3 ubiquitin ligase IpaH9.8 targets NEMO/IKKgamma to dampen the host NF-kappaBmediated inflammatory response. Nat. Cell Biol. 12(1), 66-73; sup 61-69 (2010).
143. Arbibe L, Kim DW, Batsche E et al. An injected bacterial effector targets chromatin access for transcription factor NF-kappaB to alter transcription of host genes involved in immune responses. Nat. Immunol. 8(1), 47-56 (2007).
144. Li H, Xu H, Zhou Y et al. The phosphothreonine lyase activity of a bacterial type III effector family. Science 315(5814), 1000-1003 (2007).
145. Sanada T, Kim M, Mimuro H et al. The Shigella flexneri effector OspI deamidates UBC13 to dampen the inflammatory response. Nature 483(7391), 623-626 (2012).
146. Scaletsky IC, Silva ML, Trabulsi LR. Distinctive patterns of adherence of enteropathogenic Escherichia coli to HeLa cells. Infect. Immun. 45(2), 534-536 (1984).
147. Nowicki B, Selvarangan R, Nowicki S. Family of Escherichia coli Dr adhesins: decay-accelerating factor receptor recognition and invasiveness. J. Infect. Dis. 183 (Suppl. 1), S24-S27 (2001).
148. Le Bouguenec C, Servin AL. Diffusely adherent Escherichia coli strains expressing Afa/Dr adhesins (Afa/Dr DAEC): hitherto unrecognized pathogens. FEMS Microbiol. Lett. 256(2), 185-194 (2006).
149. Servin AL. Pathogenesis of Afa/Dr diffusely adhering Escherichia coli. Clin. Microbiol. Rev.18(2), 264-292 (2005).
150. Guignot J, Peiffer I, Bernet-Camard MF et al. Recruitment of CD55 and CD66e brush border-associated glycosylphosphatidylinositol-anchored proteins by members of the Afa/Dr diffusely adhering family of Escherichia coli that infect the human polarized intestinal Caco-2/TC7 cells. Infect. Immun. 68(6), 3554-3563 (2000).
151. Betis F, Brest P, Hofman V et al. Afa/Dr diffusely adhering Escherichia coli infection in T84 cell monolayers induces increased neutrophil transepithelial migration, which in turn promotes cytokine-dependent upregulation of decay-accelerating factor (CD55), the receptor for Afa/Dr adhesins. Infect. Immun. 71(4), 1774-1783 (2003).
152. Betis F, Brest P, Hofman V et al. The Afa/Dr adhesins of diffusely adhering Escherichia coli stimulate interleukin-8 secretion, activate mitogen-activated protein kinases, and promote polymorphonuclear transepithelial migration in T84 polarized epithelial cells. Infect. Immun. 71(3), 1068-1074 (2003).
153. Semiramoth N, Gleizes A, Turbica I et al. Escherichia coli type 1 pili trigger late IL-8 production by neutrophil-like differentiated PLB-985 cells through a Src family kinaseand MAPK-dependent mechanism. J. Leuk. Biol. 85(2), 310-321 (2009).
154. Tieng V, Le Bouguenec C, Du Merle L et al. Binding of Escherichia coli adhesin AfaE to CD55 triggers cell-surface expression of the MHC class I-related molecule MICA. Proc. Natl Acad. Sci. USA 99(5), 2977-2982 (2002).
155. Arikawa K, Meraz IM, Nishikawa Y, Ogasawara J, Hase A. Interleukin-8 secretion by epithelial cells infected with diffusely adherent Escherichia coli possessing Afa adhesin-coding genes. Microbiol. Immunol. 49(6), 493-503 (2005).
156. Meraz IM, Arikawa K, Ogasawara J, Hase A, Nishikawa Y. Epithelial cells secrete interleukin-8 in response to adhesion and invasion of diffusely adhering Escherichia coli lacking Afa/Dr genes. Microbiol. Immunol. 50(3), 159-169 (2006).
157. Eckmann L, Jung HC, Schurer-Maly C, Panja A, Morzycka-Wroblewska E, Kagnoff MF. Differential cytokine expression by human intestinal epithelial cell lines: regulated expression of interleukin 8. Gastroenterology 105(6), 1689-1697 (1993).
158. Jung HC, Eckmann L, Yang SK et al. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J. Clin. Invest. 95(1), 55-65 (1995).
159. Jacewicz MS, Acheson DW, Mobassaleh M, Donohue-Rolfe A, Balasubramanian KA, Keusch GT. Maturational regulation of globotriaosylceramide, the Shiga-like toxin 1 receptor, in cultured human gut epithelial cells. J. Clin. Invest. 96(3), 1328-1335 (1995).
160. Smith WE, Kane AV, Campbell ST, Acheson DW, Cochran BH, Thorpe CM. Shiga toxin 1 triggers a ribotoxic stress response leading to p38 and JNK activation and induction of apoptosis in intestinal epithelial cells. Infect. Immun. 71(3), 1497-1504 (2003).
161. Abreu MT, Vora P, Faure E, Thomas LS, Arnold ET, Arditi M. Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J. Immunol. 167(3), 1609-1616 (2001).
162. Abreu MT, Arnold ET, Thomas LS et al. TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells. J. Biol. Chem. 277(23), 20431-20437 (2002).
163. Patlolla JM, Swamy MV, Raju J, Rao CV. Overexpression of caveolin-1 in experimental colon adenocarcinomas and human colon cancer cell lines. Oncol. Rep. 11(5), 957-963 (2004).
164. Bender FC, Reymond MA, Bron C, Quest AF. Caveolin-1 levels are down-regulated in human colon tumors, and ectopic expression of caveolin-1 in colon carcinoma cell lines reduces cell tumorigenicity. Cancer Res. 60(20), 5870-5878 (2000).
165. Couet J, Sargiacomo M, Lisanti MP. Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities. J. Biol. Chem. 272(48), 30429-30438 (1997).
166. Ju H, Zou R, Venema VJ, Venema RC. Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity. J. Biol. Chem. 272(30), 18522-18525 (1997).
167. Sargiacomo M, Sudol M, Tang Z, Lisanti MP. Signal transducing molecules and glycosylphosphatidylinositol-linked proteins form a caveolin-rich insoluble complex in MDCK cells. J. Cell Biol. 122(4), 789-807 (1993).
168. Couet J, Li S, Okamoto T, Ikezu T, Lisanti MP. Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J. Biol. Chem. 272(10), 6525-6533 (1997).
169. Engelman JA, Chu C, Lin A et al. Caveolinmediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain. FEBS Lett. 428(3), 205-211 (1998).
170. Xu J, Yang Y, Wang C, Jiang B. Rotavirus and coxsackievirus infection activated different profiles of Toll-like receptors and chemokines in intestinal epithelial cells. Inflamm. Res. 58(9), 585-592 (2009).
171. Abreu MT. Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat. Rev. Immunol. 10(2), 131-144 (2010).
172. Lacroix M. Persistent use of "false" cell lines. Int. J. Cancer 122(1), 1-4 (2008).
173. Sharma R, Tesfay S, Tomson FL, Kanteti RP, Viswanathan VK, Hecht G. Balance of bacterial pro-and anti-inflammatory mediators dictates net effect of enteropathogenic Escherichia coli on intestinal epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 290(4), G685-G694 (2006).
174. Hajishengallis G, Tapping RI, Martin MH et al. Toll-like receptor 2 mediates cellular activation by the B subunits of type II heat-labile enterotoxins. Infect. Immun. 73(3), 1343-1349 (2005).
175. Zhang L, Ding X, Cui J et al. Cysteine methylation disrupts ubiquitin-chain sensing in NF-kappaB activation. Nature 481(7380), 204-208 (2012).
176. Hemrajani C, Berger CN, Robinson KS, Marches O, Mousnier A, Frankel G. NleH effectors interact with Bax inhibitor-1 to block apoptosis during enteropathogenic Escherichia coli infection. Proc. Natl Acad. Sci. USA 107(7), 3129-3134 (2010).